封面
市场调查报告书
商品编码
1363087

ADME毒性测试市场规模、份额、趋势分析报告:按技术、按用途、按方法、细分趋势,2023-2030

ADME Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, OMICS Tech), By Application (Neurotoxicity, Renal Toxicity), By Method (Cellular Assay, In-Silica), And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

ADME 毒理学测试市场成长与趋势:

根据Grand View Research, Inc.的最新报告,预计到2030年,全球ADME毒性测试市场规模将产生192.1亿美元的收益,预测期内年复合成长率为10.2%。

製药公司采用更好的毒性测试方法,增加检查阶段药物失效的需求,预计将推动市场产生收入。

吸收、分布、代谢和排泄(ADME)毒性测试用于临床试验中,检测分子因化学、药物、遗传或其他要素引起的毒性反应或全身性反应。这些毒理学测试程序有助于开发有效的药物,限製或预防给药后体内的毒性反应。毒性水平是根据在接近自然条件下进行的一系列测试的结果确定的,代表药物和宿主之间的近实时反应。

截至2017年,大约43.0%的ADME毒性测试领域是基于细胞培养技术进行的。细胞培养技术因其接近自然条件和在细胞层面获得准确结果等优点而被广泛采用。

这些测定是在可能发生几种类型的毒性反应或毒性反应的系统上进行的。毒性试验包括全身性毒性、肾毒性、肝毒性、神经毒性以及活体组织中可能发生的其他毒性。测试方法的趋势目前正在进行中,并且可能会被许多开发药物分子的公司所采用。预计这将加速药物研发进程并促进市场成长。

ADME 毒理学测试市场报告亮点

  • 阶段药物失败比例不断上升推动了市场的发展,导致药物开发的宝贵时间和投资损失。此外,预计 OMICS 技术的成长和采用的增加将在未来年度增加产生收入。
  • 北美是 ADME 毒性测试的最大市场,因为许多製药公司竞相将新分子商业性市场。
  • 随着许多跨国和本地公司有意进入亚太和拉丁美洲的新兴市场,该市场有望显着成长。我们也致力于透过创新和成长机会提高我们在市场中的地位。

目录

第1章调查方法和范围

第2章执行摘要

第3章ADME 毒理学测试市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • ADME毒理学测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章ADME毒性测试:技术估算与趋势分析

  • ADME毒理学测试市场:要点
  • ADME 毒理学测试市场:2022 年和 2030 年趋势和市场占有率分析
  • 细胞培养
  • 高通量
  • 分子影像
  • 组学技术

第5章ADME 毒理学测试市场:按用途估算和趋势分析

  • ADME毒理学测试市场:要点
  • ADME 毒理学测试市场:2022 年和 2030 年趋势和市场占有率分析
  • 全身毒性
  • 肾毒性
  • 肝毒性
  • 神经毒性
  • 其他毒性

第6章ADME毒性测试市场:方法估算及趋势分析

  • ADME毒理学测试市场:要点
  • ADME 毒理学测试市场:2022 年和 2030 年趋势和市场占有率分析
  • 细胞测定
  • 生化测定
  • 硅胶
  • 体外

第7章ADME毒理学测试市场:区域估算与趋势分析

  • 区域展望
  • ADME毒理学测试市场(按地区):要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • Curia Global, Inc.
    • Dassault Systemes
    • Beckman Coulter, Inc., (Danaher)
    • Catalent, Inc
    • Charles River Laboratories
    • Labcorp Drug Development
    • Eurofins Scientific
    • GE HealthCare
    • Miltenyi Biotec
    • IQVIA Inc
Product Code: GVR-2-68038-627-1

ADME Toxicology Testing Market Growth & Trend:

The global ADME toxicology testing market size is expected to generate a revenue of USD 19.21 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 10.2% during the forecast period. Factors such as increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market.

Absorption, distribution, metabolism, and excretion (ADME) toxicology testing is used to test toxic reactions caused by molecules in clinical trials on factors and systemic reactions such as chemical, pharmaceutical, and genetic. These toxicology testing procedures help in effective drug development, which limits or prevents toxic reactions to the body when administered. Toxicity levels are decided on the results of a series of tests conducted in near-natural conditions, which represent almost real-time reactions between the drug and the host.

As of 2017, approximately 43.0% of ADME toxicology testing areas carried out are based on cell culture tech. Cell culture technology is adopted widely owing to advantages such as near-natural conditions and accurate results obtained at a cellular level.

These assays are conducted for several types of toxic reactions or systems where toxic reactions might take place. Some of the toxicity tests are systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other toxicities that might result in living tissue. Advancements in testing methods are underway and this trend is likely to be picked up by many companies developing drug molecules. This will speed up the drug discovery process and boost the market growth.

ADME Toxicology Testing Market Report Highlights:

  • The market is driven by an increasing ratio of late-stage drug failures, resulting in loss of valuable time and investment for drug development. Growth and increasing adoption of OMICS technology is also expected to boost revenue generation in the coming years
  • North America is the largest market for ADME toxicology testing owing to the presence of a large number of pharmaceutical companies competing for the commercial launch of novel molecules
  • Developing regions of Asia Pacific and Latin America are set to grow considerably as many multinational and local players are striving to enter the market. They are also looking to improve their hold in markets that present innovation and growth opportunities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Application
    • 1.1.3. Method
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. Method outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. ADME Toxicology Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. ADME Toxicology Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. ADME Toxicology Testing: Technology Estimates & Trend Analysis

  • 4.1. ADME Toxicology Testing Market: Key Takeaways
  • 4.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cell Culture
    • 4.3.1. Cell Culture market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. High Throughput
    • 4.4.1. High throughput market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Molecular Imaging
    • 4.5.1. Molecular imaging market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. OMICS Technology
    • 4.6.1. OMICS technology market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. ADME Toxicology Testing Market: Application Estimates & Trend Analysis

  • 5.1. ADME Toxicology Testing Market: Key Takeaways
  • 5.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Systemic Toxicity
    • 5.3.1. Systemic toxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Renal Toxicity
    • 5.4.1. Renal toxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Hepatotoxicity
    • 5.5.1. Hepatotoxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Neurotoxicity
    • 5.6.1. Neurotoxicity market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Other Toxicities
    • 5.7.1. Other toxicities market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. ADME Toxicology Testing Market: Method Estimates & Trend Analysis

  • 6.1. ADME Toxicology Testing Market: Key Takeaways
  • 6.2. ADME Toxicology Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Cellular Assay
    • 6.3.1. Cellular assay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Biochemical Assay
    • 6.4.1. Biochemical assay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. In-Silica
    • 6.5.1. In-silica market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Ex-vivo
    • 6.6.1. Ex-vivo market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. ADME Toxicology Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. ADME Toxicology Testing Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Thermo Fisher Scientific Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Promega Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Agilent Technologies, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Curia Global, Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Dassault Systemes
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Beckman Coulter, Inc., (Danaher)
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Catalent, Inc
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Charles River Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Labcorp Drug Development
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Eurofins Scientific
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. GE HealthCare
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Miltenyi Biotec
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. IQVIA Inc
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 3 North America ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 5 North America ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 7 U.S. ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 9 Canada ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Canada ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 12 Europe ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Europe ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 15 Europe ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Germany ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 19 UK ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 20 UK ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 22 France ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 25 Italy ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Italy ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 28 Spain ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Spain ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 31 Sweden ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Sweden ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 34 Norway ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Norway ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 37 Denmark ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Denmark ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Japan ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 47 China ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 48 China ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 50 India ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 51 India ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 53 Australia ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Australia ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 56 Thailand ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Thailand ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 59 South Korea ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Korea ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 62 Latin America ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Latin America ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 65 Latin America ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Brazil ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 69 Mexico ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 70 Mexico ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 72 Argentina ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Argentina ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa ADME toxicology testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 80 South Africa ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 85 UAE ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 86 UAE ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE ADME toxicology testing market, by method, 2018 - 2030 (USD Million)
  • Table 88 Kuwait ADME toxicology testing market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Kuwait ADME toxicology testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait ADME toxicology testing market, by method, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 ADME toxicology testing: Market outlook
  • Fig. 9 ADME toxicology testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 ADME toxicology testing market driver impact
  • Fig. 15 ADME toxicology testing market restraint impact
  • Fig. 16 ADME toxicology testing market strategic initiatives analysis
  • Fig. 17 ADME toxicology testing market: Technology movement analysis
  • Fig. 18 ADME toxicology testing market: Technology outlook and key takeaways
  • Fig. 19 Cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 High throughput market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Molecular imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 OMICS technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 ADME toxicology testing market: Application movement analysis
  • Fig. 24 ADME toxicology testing market: Application outlook and key takeaways
  • Fig. 25 Systemic toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Renal toxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hepatotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Neurotoxicity market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Other toxicities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 ADME toxicology testing market: Method movement analysis
  • Fig. 31 ADME toxicology testing market: Method outlook and key takeaways
  • Fig. 32 Cellular assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Biochemical assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 In-silica market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Ex-vivo market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Global ADME toxicology testing market: Regional movement analysis
  • Fig. 37 Global ADME toxicology testing market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)